Author = Mohamed El-Zahabi
Number of Articles: 10
INSIGHTS INTO MOLECULAR GLUE DEGRADERS: A REVIEW

Volume 70, Issue 2, September 2024, Pages 74-102

Mohamed Ayman ALy El-Zahabi; Abdullah El-Nagar; Hazem Elkady

DUAL INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) AND TRYPTOPHAN-2,3-DIOXYGENASE (TDO) AS ANTI-TUMOR IMMUNE MODULATORS

Volume 69, Issue 1, March 2024, Pages 38-61

Mohamed Ayman ALy El-Zahabi; Mostafa Youssef Abouzeid; Ibrahim H Eissa; Mohamed S Taghour

PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS

Volume 68, Issue 2, September 2023, Pages 64-81

Mohamed Ayman ALy El-Zahabi; Reda G Yousef; Ibrahim H Eissa; Alaa Elwan

EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS

Volume 68, Issue 2, September 2023, Pages 82-110

Abdelsalam Mohamed Ouf; Adel A Marzouk; Montaser A Shykhoon; Mohamed Ayman ALy El-Zahabi

AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS

Volume 68, Issue 2, September 2023, Pages 130-158

Mostafa Mohammed Aref; Abeer A Mohamed; Mohammed A Dahab; Mohamed Ayman ALy El-Zahabi

AN OVERVIEW OF IMIDES AND THEIR ANALOGUES AS ANTICANCER AGENTS

Volume 66, Issue 2, September and October 2022, Pages 99-125

Mohamed El-Zahabi; Yahia Amin; Helmy Sakr; Omar El-Hady

Al-Azhar Journal of Pharmaceutical Sciences

Journal Archive